文献速递产科母胎医学

先天性心脏病与依外显子组测序诊断率(CODE)研究:前瞻性队列研究与系统综述

COngenital heart disease and the Diagnostic yield with Exome sequencing (CODE) study: prospective cohort study and systematic review.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-12-03

该前瞻性队列纳入197个因产前诊断先天性心脏病(CHD)而接受染色体微阵列分析(CMA)或核型分析后行外显子组测序(ES)的核心家系,并系统综述18项研究(636例CHD)。队列中ES在全部CHD、孤立性CHD和CHD合并心外畸形(ECA)的额外诊断率分别为12.7%、11.5%和14.7%;系统综述汇总的相应增量诊断率分别为21%、11%和37%。

要点

  • 产前ES在CHD中具有额外诊断价值,合并ECA时增量诊断率最高。
  • 孤立性CHD的ES增量诊断率约为11%,可考虑对此类病例行ES。
  • 多数致病变异为新发且位于常染色体显性基因,Kabuki综合征最常见。

核心结论

  • 产前ES在CHD中显示出明显的增量诊断率。
  • 合并ECA时增量诊断率最高,但孤立性心脏异常也可考虑行ES。
  • 常规应用ES需建立稳健的生物信息学、临床和伦理路径。

研究设计与样本

  • 前瞻性队列研究纳入197个因产前诊断CHD而接受CMA或核型分析后行ES的核心家系。
  • 纳入标准为病例数超过3例、仅基于产前表型启动检测且CMA或核型分析阴性的研究。

主要发现

  • 队列中ES在全部CHD、孤立性CHD和CHD合并ECA的额外诊断率分别为12.7%(25/197)、11.5%(14/122)和14.7%(11/75),P=0.81。
  • 系统综述18项研究(636例CHD)汇总的增量诊断率分别为21%(95%CI 15-27%)、11%(95%CI 7-15%)和37%(95%CI 18-56%)。
  • 限制于病例数超过20例的研究时,除CHD合并ECA外结果无显著差异,后者增量诊断率为49%(95%CI 17-80%)。
  • CHD合并ECA中,与致病变异相关的最常见心外畸形为泌尿生殖系统异常(23/52,44.2%)。
  • 增量诊断率最高的亚组为心脏分流病变(41%,95%CI 19-63%),其次为右侧病变(26%,95%CI 9-43%)。

临床怎么用

  • 产前诊断CHD后,尤其合并ECA时,应考虑在CMA或核型分析阴性后行ES。
  • 孤立性心脏异常也可考虑行ES,以获取额外遗传诊断。
  • ES结果解读需结合新发常染色体显性基因变异模式及Kabuki综合征等单基因综合征。

局限性

  • 系统综述纳入研究间异质性可能影响汇总结果。
  • 常规应用ES需解决生物信息学、临床和伦理路径问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the incremental yield of antenatal exome sequencing (ES) over chromosomal microarray analysis (CMA) or conventional karyotyping in prenatally diagnosed congenital heart disease (CHD). METHODS: A prospective cohort study of 197 trios undergoing ES following CMA or karyotyping owing to CHD identified prenatally and a systematic review of the literature were performed. MEDLINE, EMBASE, CINAHL and ClinicalTrials.gov (January 2000 to October 2019) databases were searched electronically for studies reporting on the diagnostic yield of ES in prenatally diagnosed CHD. Selected studies included those with more than three cases, with initiation of testing based upon prenatal phenotype only and that included cases in which CMA or karyotyping was negative. The incremental diagnostic yield of ES was assessed in: (1) all cases of CHD; (2) isolated CHD; (3) CHD associated with extracardiac anomaly (ECA); and (4) CHD according to phenotypic subgroup. RESULTS: In our cohort, ES had an additional diagnostic yield in all CHD, isolated CHD and CHD associated with ECA of 12.7% (25/197), 11.5% (14/122) and 14.7% (11/75), respectively (P = 0.81). The corresponding pooled incremental yields from 18 studies (encompassing 636 CHD cases) included in the systematic review were 21% (95% CI, 15-27%), 11% (95% CI, 7-15%) and 37% (95% CI, 18-56%), respectively. The results did not differ significantly when subanalysis was limited to studies including more than 20 cases, except for CHD associated with ECA, in which the incremental yield was greater (49% (95% CI, 17-80%)). In cases of CHD associated with ECA in the primary analysis, the most common extracardiac anomalies associated with a pathogenic variant were those affecting the genitourinary system (23/52 (44.2%)). The greatest incremental yield was in cardiac shunt lesions (41% (95% CI, 19-63%)), followed by right-sided lesions (26% (95% CI, 9-43%)). In the majority (68/96 (70.8%)) of instances, pathogenic variants occurred de novo and in autosomal dominant (monoallelic) disease genes. The most common (19/96 (19.8%)) monogenic syndrome identified was Kabuki syndrome. CONCLUSIONS: There is an apparent incremental yield of prenatal ES in CHD. While the greatest yield is in CHD associated with ECA, consideration could also be given to performing ES in the presence of an isolated cardiac abnormality. A policy of routine application of ES would require the adoption of robust bioinformatic, clinical and ethical pathways. Copyright © 2020 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Mone F, Eberhardt RY, Morris RK, et al. COngenital heart disease and the Diagnostic yield with Exome sequencing (CODE) study: prospective cohort study and systematic review. Ultrasound Obstet Gynecol. 2020. PMID: 32388881. doi:10.1002/uog.22072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。